Vispo E - Search Results

1

Fernández-Montero JV, Vispo E, Soriano V. Fernández-Montero JV, et al. Among authors: vispo e. Expert Opin Pharmacother. 2014 Feb;15(2):211-9. doi: 10.1517/14656566.2014.863277. Epub 2013 Nov 30. Expert Opin Pharmacother. 2014. PMID: 24289800 Review.

2

Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection.

Fernández-Montero JV, Vispo E, Anta L, de Mendoza C, Soriano V. Fernández-Montero JV, et al. Among authors: vispo e. Expert Opin Pharmacother. 2012 May;13(7):1007-14. doi: 10.1517/14656566.2012.667802. Expert Opin Pharmacother. 2012. PMID: 22519768

3

Pharmacokinetics of new oral hepatitis C antiviral drugs.

Vispo E, Barreiro P, Soriano V. Vispo E, et al. Expert Opin Drug Metab Toxicol. 2013 Jan;9(1):5-16. doi: 10.1517/17425255.2013.729577. Epub 2012 Oct 25. Expert Opin Drug Metab Toxicol. 2013. PMID: 23094639 Review.

4

Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.

Fernández-Montero JV, Barreiro P, Vispo E, Labarga P, Sánchez-Parra C, Soriano V. Fernández-Montero JV, et al. Among authors: vispo e. AIDS. 2013 Apr 24;27(7):1129-34. doi: 10.1097/QAD.0b013e32835e063f. AIDS. 2013. PMID: 23276803

5

Hepatitis C therapy with HCV NS5B polymerase inhibitors.

Soriano V, Vispo E, de Mendoza C, Labarga P, Fernandez-Montero JV, Poveda E, Treviño A, Barreiro P. Soriano V, et al. Among authors: vispo e. Expert Opin Pharmacother. 2013 Jun;14(9):1161-70. doi: 10.1517/14656566.2013.795543. Epub 2013 Apr 27. Expert Opin Pharmacother. 2013. PMID: 23621117 Review.

6

Update on HIV/HCV coinfection.

Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P. Soriano V, et al. Among authors: vispo e. Curr HIV/AIDS Rep. 2013 Sep;10(3):226-34. doi: 10.1007/s11904-013-0169-5. Curr HIV/AIDS Rep. 2013. PMID: 23832718 Review.

7

Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy.

Fernández-Montero JV, Barreiro P, Vispo E, Labarga P, Sánchez-Parra C, de Mendoza C, Treviño A, Soriano V. Fernández-Montero JV, et al. Among authors: vispo e. Antivir Ther. 2014;19(3):287-92. doi: 10.3851/IMP2703. Epub 2013 Nov 5. Antivir Ther. 2014. PMID: 24192598

8

Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy.

Vispo E, Barreiro P, Plaza Z, Fernández-Montero JV, Labarga P, de Mendoza C, Sierra-Enguita R, Treviño A, Lopez M, Soriano V. Vispo E, et al. AIDS. 2014 Jun 19;28(10):1473-8. doi: 10.1097/QAD.0000000000000275. AIDS. 2014. PMID: 24637541

9

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.

Blanco F, Barreiro P, Ryan P, Vispo E, Martín-Carbonero L, Tuma P, Labarga P, Medrano J, González-Lahoz J, Soriano V. Blanco F, et al. Among authors: vispo e. J Viral Hepat. 2011 Jan;18(1):11-6. doi: 10.1111/j.1365-2893.2009.01261.x. J Viral Hepat. 2011. PMID: 20088890

10

Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.

Labarga P, Fernandez-Montero JV, Barreiro P, Pinilla J, Vispo E, de Mendoza C, Plaza Z, Soriano V. Labarga P, et al. Among authors: vispo e. J Viral Hepat. 2014 Jul;21(7):475-9. doi: 10.1111/jvh.12180. Epub 2013 Oct 6. J Viral Hepat. 2014. PMID: 24750394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page